Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population

Sabrina Cordua, Lasse Kjaer, Vibe Skov, Niels Pallisgaard, Hans C. Hasselbalch, Christina Ellervik

Blood (2019) 134 (5): 469–479.

https://doi.org/10.1182/blood.2019001113

Published: 2019

Includes: Supplemental data

Journal Articles

The Impact of the Mutational Landscape upon the Molecular Responses to Interferon-Alfa2 in Calr-Mutated MPN Patients

Vibe Skov, PhD, Lasse Kjær, PhD, Mads Thomassen, PhD, Steffen Koschmieder, MD, Julia Czech, Nicolas Chatain, PhD, Niels Pallisgaard, Sabrina Cordua, MD, Torben A Kruse, Hans Carl Hasselbalch, Professor, dr.MD

Blood (2018) 132 (Supplement 1): 4327.

https://doi.org/10.1182/blood-2018-99-119158

Published: 2018

Journal Articles

A Heterogeneous Response Pattern to Interferon-alpha2 with Induction of a Significant Decrease in the Calreticulin Mutant Allele Burden in a Subset of Patients with Essential Thrombocythemia and Primary Myelofibrosis

Sabrina Cordua, MD, Lasse Kjaer, PhD, Morten Orebo Holmström, MD, Niels Pallisgaard, MSc, Vibe Skov, MSc, PhD, Hans Hasselbalch, MD

Blood (2015) 126 (23): 4057.

https://doi.org/10.1182/blood.V126.23.4057.4057

Published: 2015

Journal Articles

Safety and Efficacy of Combination Therapy of Interferon-Alpha2 + JAK1-2 Inhibitor in the Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Preliminary Results from the Danish Combi-Trial - an Open Label, Single Arm, Non-Randomized Multicenter Phase II Study

Stine Ulrik Mikkelsen, MD, Lasse Kjær, MSc, PhD, Vibe Skov, MSc, PhD, Mads Emil Bjørn, MD PhDStudent, Christen Lykkegaard Andersen, MD PhD, Ole Weis Bjerrum, MD DMSc, Nana Brochmann, MD PhDStudent, Daniel El Fassi, MD PhD, Torben A Kruse, Professor, PhD, Thomas Stauffer Larsen, MD PhD, Torben Mourits-Andersen, MD, Claus Henrik Nielsen, MD Professor, DMSc, Niels Pallisgaard, MSc, Mads Thomassen, MSc, PhD, Hans Carl Hasselbalch, MD Professor, DMSc

Blood (2015) 126 (23): 824.

https://doi.org/10.1182/blood.V126.23.824.824

Published: 2015

Journal Articles

Exceeding MR5.0 Sensitivity in Routine BCR-ABL1 Analysis Using Multiplex Digital PCR

Rikke Fredslund Andersen, PhD, Niels Pallisgaard

Blood (2014) 124 (21): 4540.

https://doi.org/10.1182/blood.V124.21.4540.4540

Published: 2014

Journal Articles

Potential of Digital PCR in CML Calibration

Niels Pallisgaard, Morten T. Andersen, Anni Aggerholm, PhD, Hans Ehrencrona, MD PhD, Beatriz Bellosillo, Elisabeth Oppliger Leibundgut, PharmD

Blood (2014) 124 (21): 1817.

https://doi.org/10.1182/blood.V124.21.1817.1817

Published: 2014

Journal Articles

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Sylvie Hermouet, MD, PhD, Eric Lippert, PhD, Niels Pallisgaard, Jiri Schwarz, MD, PhD, Mary Frances McMullin, MD, Lars Palmqvist, MD, PhD, Heike L Pahl, Ph.D., Beatriz Bellosillo Paricio, Celeste Bento, Serge Carillo, Stephane Giraudier, MD, PhD, Francois Girodon, MD, PhD, Melanie Percy, PhD, FRCPath, Lukas Plank, Susanne Schnittger, PhD, Radek C. Skoda, MD, Alessandro M. Vannucchi, MD

Blood (2011) 118 (21): 2809.

https://doi.org/10.1182/blood.V118.21.2809.2809

Published: 2011

Journal Articles

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed within the European LeukemiaNet (ELN).

Charlotte G Nyvold, M.Sci., PhD, Mette Oestergaard, M.Sci., PhD, Morten T Andersen, M.Sci., Jelena V Jovanovic, Veli Kairisto, M.D., PhD, Jan K Larsen, MM.Sci., Yvonne G Morgan, Dr., Ugur Ozbek, M.D., PhD, Prof., Niels Pallisgaard, M.Sci., Heike Pfeifer, M.D., David Grimwade, PhD, FRCPath, Peter Hokland, M.D., D., Med., Sci.

Blood (2009) 114 (22): 1619.

https://doi.org/10.1182/blood.V114.22.1619.1619

Published: 2009

Journal Articles

Bone Marrow Microenvironmental Overexpression of DKK1, HGF, Frizzled-Related Protein B, and Syndecan-1 Are Associated with the Degree of Osteolytic Bone Disease in Multiple Myeloma Patients

Jacob Haaber, Gitte Birk Kerndrup, Maria Lyng, Thomas L. Andersen, Niels Pallisgaard, Niels Abildgaard

Blood (2008) 112 (11): 5139.

https://doi.org/10.1182/blood.V112.11.5139.5139

Published: 2008

Journal Articles

Limited Efficacy of Hydroxyurea in Lowering of the JAK2 V617F Allele Burden.

Thomas Stauffer Larsen, Niels Pallisgaard, Karin de Stricker, Michael Boe Møller, Hans Carl Hasselbalch

Blood (2008) 112 (11): 1750.

https://doi.org/10.1182/blood.V112.11.1750.1750

Published: 2008

Journal Articles

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Blood (2007) 110 (11): 4559.

https://doi.org/10.1182/blood.V110.11.4559.4559

Published: 2007

Journal Articles

Quantitative PCR Assessment of JAK2 Mutational Status in Philadelphia-Chromosome Negative Chronic Myeloproliferative Disorders - The JAK2 V617F Mutation Is an Event in an Early Stem Cell and the Clonal Involvement of Different Haematopoietic Cells Varies between Individual Patients.

Thomas S. Larsen, MD, Hans C. Hasselbalch, M.D DMsc, Niels Pallisgaard

Blood (2006) 108 (11): 3602.

https://doi.org/10.1182/blood.V108.11.3602.3602

Published: 2006

Journal Articles

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis

Blood (2006) 107 (5): 2098–2100.

https://doi.org/10.1182/blood-2005-08-3395

Published: 2006

Journal Articles

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Enrico Gottardi, Daniela Cilloni, MD, Sarah Daly, S. Green, Niels Pallisgaard, P. Hokland, MD, M. Ostergaard, C. Nyvold, J. Nomdedeu, MD, Fabrizio Pane, MD, Susanne Schnittger, Vincent Van der Velden, Kalid Tobal, Y. Yin Jal, Fabienne Hermitte, Teo De Witte, R. Hehlmann, Giuseppe Saglio, MD, David Grimwade, MD

Blood (2005) 106 (11): 3295.

https://doi.org/10.1182/blood.V106.11.3295.3295

Published: 2005

Journal Articles

Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Translocations and Chromosomal Aberrations in Acute Leukemia

Niels Pallisgaard, Peter Hokland, Dorthe C. Riishøj, Bent Pedersen, Poul Jørgensen

Blood (1998) 92 (2): 574–588.

https://doi.org/10.1182/blood.V92.2.574

Published: 1998

NARROW

Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population

The Impact of the Mutational Landscape upon the Molecular Responses to Interferon-Alfa2 in Calr-Mutated MPN Patients

A Heterogeneous Response Pattern to Interferon-alpha2 with Induction of a Significant Decrease in the Calreticulin Mutant Allele Burden in a Subset of Patients with Essential Thrombocythemia and Primary Myelofibrosis

Safety and Efficacy of Combination Therapy of Interferon-Alpha2 + JAK1-2 Inhibitor in the Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Preliminary Results from the Danish Combi-Trial - an Open Label, Single Arm, Non-Randomized Multicenter Phase II Study

Exceeding MR5.0 Sensitivity in Routine BCR-ABL1 Analysis Using Multiplex Digital PCR

Potential of Digital PCR in CML Calibration

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Development of Standardized Approaches to Reporting of Minimal Residual Disease Data Using a Reporting Software Package Designed within the European LeukemiaNet (ELN).

Bone Marrow Microenvironmental Overexpression of DKK1, HGF, Frizzled-Related Protein B, and Syndecan-1 Are Associated with the Degree of Osteolytic Bone Disease in Multiple Myeloma Patients

Limited Efficacy of Hydroxyurea in Lowering of the JAK2 V617F Allele Burden.

Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale.

Quantitative PCR Assessment of JAK2 Mutational Status in Philadelphia-Chromosome Negative Chronic Myeloproliferative Disorders - The JAK2 V617F Mutation Is an Event in an Early Stem Cell and the Clonal Involvement of Different Haematopoietic Cells Varies between Individual Patients.

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis

Standardization of WT1 mRNA Quantification for Minimal Residual Disease (MRD) Monitoring in Acute Leukemia Patients: A European LeukemiaNet Concerted Action.

Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Translocations and Chromosomal Aberrations in Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only